In a cohort of patients with Down syndrome and AVSD, variants with the highest probability of being damaging in cases compared to Down syndrome patients without cardiac defects were in the VEGF-A pathway genes COL6A1, COL6A2, CRELD1, FBLN2, FRZB, and GATA5 [123]. This evidence concerns the gene GATA5 and Down syndrome.